Neo Ivy Capital Management’s Repligen RGEN Stock Holding History

Neo Ivy Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,394	Closed	-$164K	–	474
2026 Q1	$164K	Buy	+1,394	New	+$195K	0.04%	272
2025 Q2	–	Sell	-16,436	Closed	-$2.09M	–	452
2025 Q1	$2.09M	Buy	+16,436	New	+$2.53M	0.67%	61
2024 Q3	–	Sell	-23,148	Closed	-$2.92M	–	376
2024 Q2	$2.92M	Buy	+23,148	New	+$3.63M	0.57%	80
2023 Q4	$164K	Buy	+912	New	+$142K	0.37%	93
2023 Q3	–	Sell	-2,094	Closed	-$296K	–	436
2023 Q2	$296K	Buy	+2,094	New	+$336K	0.16%	197
2021 Q4	–	Sell	-39	Closed	-$5K	–	599
2021 Q3	$5K	Buy	+39	New	+$10K	0.01%	428
2021 Q2	–	Sell	-291	Closed	-$57K	–	583
2021 Q1	$57K	Buy	+291	New	+$59.7K	0.06%	317
2020 Q3	–	Sell	-39	Closed	-$5K	–	593
2020 Q2	$5K	Sell	39 -1,396	-97%	-$164K	0.01%	428
2020 Q1	$139K	Buy	+1,435	New	+$139K	0.23%	182
2019 Q1	–	Sell	-6,831	Closed	-$360K	–	384
2018 Q4	$360K	Buy	+6,831	New	+$401K	0.28%	157

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neo Ivy Capital Management's RGEN Position: Q2 2026 in Review

Neo Ivy Capital Management sold out of Repligen (RGEN) in Q2 2026, closing a stake of 1,394 shares — an estimated $164K sold.

Neo Ivy Capital Management first reported a position in RGEN in Q4 2018 and held it in 10 quarters. The position peaked at $2.92M in Q2 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Neo Ivy Capital Management reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
Neo Ivy Capital Management sold 1,394 Repligen shares in Q2 2026, an estimated $164K.
Neo Ivy Capital Management first reported a position in Repligen in Q4 2018 and held it in 10 quarters.
Neo Ivy Capital Management's Repligen position peaked at $2.92M in Q2 2024.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.